Sign in
A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)
Journal article   Peer reviewed

A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)

Melissa Alsina, C. Ola Landgren, Noopur Raje, Ruben Niesvizky, William I Bensinger, Jesus Berdeja, Tibor Kovacsovics, David Vesole, Belle Fang, Amy Kimball, …
Clinical lymphoma, myeloma and leukemia, Vol.19(10), pp.e52-e52
2019-10

Metrics

10 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details